Duan W, Yang S, Zhao T, Hu L, et al. Comparison of efficacy between homoharringtonine, aclarubicin, cytarabine (HAA) and idarubicin, cytarabine (IA) regimens as induction therapy in patients with de novo core binding factor acute myeloid leukemia. Ann Hematol 2023 Aug 12. doi: 10.1007/s00277-023-05400.
PMID: 37572135